FILE PHOTO: Vials labelled "COVID-19 Coronavirus Vaccine" and sryinge are seen in front of displayed Johnson&Johnson logo in this illustration taken, February 9, 2021. REUTERS/Dado Ruvic/Illustration
(Reuters) -Johnson & Johnson said on Wednesday it had found a problem with a batch of the drug substance for its COVID-19 vaccine being produced by Emergent Biosolutions, and said the batch did not advance to the final fill-and-finish stage.
J&J did not say how many vaccine doses the batch would have produced. The New York Times reported that about 15 million doses were ruined, without citing a source.
Subscribe to The Star Yearly Premium Plan for 30% off
Cancel anytime. Ad-free. Full access to Web and App.
Monthly Plan
RM 13.90/month
RM 9.73/month
Billed as RM 9.73 for the 1st month, RM 13.90 thereafter.
Annual Plan
RM 12.39/month
RM 8.63/month
Billed as RM 103.60 for the 1st year, RM 148 thereafter.
